Welcome, Sign In
FDA Launches Rare Review Into Diabetes Drugs
Description:Federal regulators are looking into a multibillion-dollar class of diabetes drugs after recent reports that they could be linked to pancreatic cancer. Peter Landers reports on The News Hub.
diabetes drugs linked to pancreatic cancer
fda launches probe into diabetes drugs
The Wall Street Journal